[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL164850A0 - Gene therapy for kidney diseases - Google Patents

Gene therapy for kidney diseases

Info

Publication number
IL164850A0
IL164850A0 IL16485004A IL16485004A IL164850A0 IL 164850 A0 IL164850 A0 IL 164850A0 IL 16485004 A IL16485004 A IL 16485004A IL 16485004 A IL16485004 A IL 16485004A IL 164850 A0 IL164850 A0 IL 164850A0
Authority
IL
Israel
Prior art keywords
gene therapy
kidney diseases
kidney
diseases
therapy
Prior art date
Application number
IL16485004A
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL16485004A priority Critical patent/IL164850A0/en
Priority to PCT/IL2005/001119 priority patent/WO2006046243A1/en
Publication of IL164850A0 publication Critical patent/IL164850A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/22011Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22041Use of virus, viral particle or viral elements as a vector
    • C12N2710/22043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16485004A 2004-10-26 2004-10-26 Gene therapy for kidney diseases IL164850A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL16485004A IL164850A0 (en) 2004-10-26 2004-10-26 Gene therapy for kidney diseases
PCT/IL2005/001119 WO2006046243A1 (en) 2004-10-26 2005-10-26 Sv40 for gene therapy of renal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16485004A IL164850A0 (en) 2004-10-26 2004-10-26 Gene therapy for kidney diseases

Publications (1)

Publication Number Publication Date
IL164850A0 true IL164850A0 (en) 2005-12-18

Family

ID=35637369

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16485004A IL164850A0 (en) 2004-10-26 2004-10-26 Gene therapy for kidney diseases

Country Status (2)

Country Link
IL (1) IL164850A0 (en)
WO (1) WO2006046243A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119096A2 (en) * 2005-04-29 2006-11-09 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Infectious particle composition and methods of use thereof
IL176377A0 (en) 2006-06-18 2006-10-05 Ariella Oppenheim Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders
JPWO2011030682A1 (en) * 2009-09-09 2013-02-07 国立大学法人東京工業大学 Viral shell-constituting protein-coated structure and method for producing the same
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
KR20210005624A (en) 2018-04-23 2021-01-14 게자 에이디 리미티드 Nucleic acid origami structure encapsulated in capsid units

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145463A0 (en) * 2001-09-16 2002-06-30 Yissum Res Dev Co A packaging complementation cell-line for sv40 vectors

Also Published As

Publication number Publication date
WO2006046243A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
GB0423554D0 (en) Therapeutic compounds
IL179145A0 (en) Therapeutic compounds
IL181305A0 (en) Combinations for the treatment of diseases involving cell proliferation
IL177155A0 (en) Therapeutic combinations
GB0420424D0 (en) Therapeutic compounds
GB0406728D0 (en) Gene therapy
GB0327384D0 (en) Gene therapy
IL164850A0 (en) Gene therapy for kidney diseases
GB0427138D0 (en) Therapeutic compounds
EP1646282A4 (en) Genetic vaccines for cancer therapy
GB0423767D0 (en) Therapeutic compounds
GB0417560D0 (en) Therapeutic compounds
GB0421918D0 (en) Cancer therapeutic target
GB0414885D0 (en) Cancer therapy
IL165427A0 (en) Targeted therapeutic proteins
AU2004904834A0 (en) Therapeutic Method - II
HK1097536A (en) Therapeutic agents ii
AU2004906949A0 (en) Therapeutic Agents
HK1097542A (en) Therapeutic agents
HK1107697A (en) Therapeutic agents
GB0427841D0 (en) Therapeutic compounds
GB0407480D0 (en) Therapeutic compounds
GB0420615D0 (en) Therapeutic compounds
GB0405012D0 (en) Therapeutic compounds